The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Eledon Pharmaceuticals Inc (NASDAQ: ELDN) closed at $3.62 in the last session, down -2.95% from day before closing price of $3.73. In other words, the price has decreased by -$2.95 from its previous closing price. On the day, 0.54 million shares were traded. ELDN stock price reached its highest trading level at $3.85 during the session, while it also had its lowest trading level at $3.6.
Ratios:
We take a closer look at ELDN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 13.91 and its Current Ratio is at 13.91. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On January 28, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELDN now has a Market Capitalization of 216772112 and an Enterprise Value of 92771024.
Stock Price History:
The Beta on a monthly basis for ELDN is -0.12, which has changed by 0.27017546 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, ELDN has reached a high of $5.54, while it has fallen to a 52-week low of $2.38. The 50-Day Moving Average of the stock is 15.21%, while the 200-Day Moving Average is calculated to be -1.95%.
Shares Statistics:
According to the various share statistics, ELDN traded on average about 423.80K shares per day over the past 3-months and 629690 shares per day over the past 10 days. A total of 59.88M shares are outstanding, with a floating share count of 55.34M. Insiders hold about 7.58% of the company’s shares, while institutions hold 59.43% stake in the company. Shares short for ELDN as of 1752537600 were 3105017 with a Short Ratio of 7.33, compared to 1749772800 on 1329307. Therefore, it implies a Short% of Shares Outstanding of 3105017 and a Short% of Float of 5.8000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of Eledon Pharmaceuticals Inc (ELDN).The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.16 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.49 and -$1.02 for the fiscal current year, implying an average EPS of -$0.82. EPS for the following year is -$1.0, with 4.0 analysts recommending between -$0.72 and -$1.2.
